MediciNova Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . MediciNova
MNOV Stock  USD 1.76  0.07  3.83%   
MediciNova financial statements provide useful quarterly and yearly information to potential MediciNova investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MediciNova financial statements helps investors assess MediciNova's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MediciNova's valuation are summarized below:
Market Capitalization
85.3 M
Enterprise Value Revenue
38.7404
Earnings Share
(0.23)
There are over one hundred nineteen available fundamental ratios for MediciNova, which can be analyzed over time and compared to other ratios. All traders should should check MediciNova's last-minute fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 99.2 M in 2025. Enterprise Value is likely to climb to about 82.8 M in 2025

MediciNova Total Revenue

1,000,000

Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.8 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
  
Check out the analysis of MediciNova Correlation against competitors.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

MediciNova Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets62.3 M55.9 M50.9 M
Slightly volatile
Total Stockholder Equity51.2 M52.5 M46.2 M
Slightly volatile
Common Stock Shares Outstanding59.2 M56.4 M35.2 M
Slightly volatile
Liabilities And Stockholders Equity62.3 M76.2 M52.2 M
Slightly volatile
Other Stockholder Equity331 M549.9 M376.7 M
Slightly volatile
Total Liabilities3.2 M3.4 M4.2 M
Pretty Stable
Other Current Liabilities120.5 K126.8 K1.3 M
Pretty Stable
Total Current Liabilities4.4 M3 M2.3 M
Slightly volatile
Property Plant And Equipment Net244.5 K382.4 K212.2 K
Slightly volatile
Accounts Payable729.6 K1.1 M590.1 K
Slightly volatile
Cash32.7 M40.4 M32.3 M
Slightly volatile
Non Current Assets Total15.4 M14.8 M14.1 M
Slightly volatile
Cash And Short Term Investments35.9 M45.9 M35.4 M
Slightly volatile
Common Stock Total Equity31.3 K56.4 K34.2 K
Slightly volatile
Non Current Liabilities Total392.6 K413.3 K2.1 M
Slightly volatile
Other Current Assets805.2 K714.5 K578.3 K
Very volatile
Property Plant And Equipment Gross421.4 K785.1 K329.8 K
Slightly volatile
Total Current Assets37.8 M41.1 M36.1 M
Slightly volatile
Common Stock32.4 K56.4 K34.3 K
Slightly volatile
Other Liabilities220.5 K232.1 K1.4 M
Slightly volatile
Non Currrent Assets Other18 K19 K1.4 B
Slightly volatile
Property Plant Equipment38.7 K40.7 K68.4 K
Slightly volatile
Short and Long Term Debt Total184.6 K194.3 K12 M
Slightly volatile
Current Deferred Revenue2.1 M2.2 M847.9 M
Pretty Stable
Good Will10.5 M11 M9.7 M
Slightly volatile
Short Term Debt184.6 K194.3 K1.1 B
Slightly volatile
Intangible Assets4.8 M4.3 M5.3 M
Slightly volatile
Net Tangible Assets41.2 M69.7 M39.7 M
Slightly volatile
Capital Surpluse427.3 M549.1 M401.5 M
Slightly volatile
Deferred Long Term Liabilities172.5 K181.6 K2.1 M
Slightly volatile
Net Receivables4.8 M5.4 M5.9 M
Slightly volatile
Net Invested Capital72.4 M52.5 M54.4 M
Slightly volatile
Net Working Capital57.4 M38.1 M40.8 M
Slightly volatile
Capital Stock51.4 K56.4 K45.2 K
Slightly volatile
Non Current Liabilities Other372.1 K211.5 K254.9 K
Slightly volatile
Capital Lease Obligations194.7 K193.8 K183.8 K
Very volatile

MediciNova Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses14.5 M9.8 M11.9 M
Slightly volatile
Research Development7.8 M7.2 M5.5 M
Slightly volatile
Total Operating Expenses14.2 M12.7 M12 M
Slightly volatile
Selling General Administrative5.2 M5.5 M203.8 M
Slightly volatile
Selling And Marketing Expenses220.5 K232.1 K195.4 M
Slightly volatile
Interest Income1.8 M1.7 M569.2 K
Slightly volatile
Reconciled Depreciation18.4 K21.1 K25 K
Slightly volatile
Extraordinary Items560 K630 K686.9 K
Slightly volatile

MediciNova Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow30.7 M51 M31.2 M
Slightly volatile
Depreciation25.3 K21.1 K33.3 K
Slightly volatile
Capital Expenditures85089522.3 K
Slightly volatile
Total Cash From Financing Activities39.2 B37.3 B6.8 B
Slightly volatile
End Period Cash Flow32.7 M40.4 M32.3 M
Slightly volatile
Stock Based Compensation1.1 M1.2 M2.1 B
Slightly volatile
Change To Netincome835.8 K879.7 K2.2 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10784.642.2666
Slightly volatile
PTB Ratio1.631.062.5778
Very volatile
Days Sales Outstanding292329358
Slightly volatile
Book Value Per Share1.391.4611.3403
Slightly volatile
Average Payables633.7 K821.4 K560 K
Pretty Stable
Stock Based Compensation To Revenue0.780.824.4 K
Slightly volatile
Capex To Depreciation1.141.211.001
Pretty Stable
PB Ratio1.631.062.5778
Very volatile
Payables Turnover0.550.580.2832
Pretty Stable
Sales General And Administrative To Revenue5.455.73406
Slightly volatile
Average Inventory0.40.450.4906
Slightly volatile
Research And Ddevelopement To Revenue6.186.514.8162
Slightly volatile
Capex To Revenue0.02330.02450.0636
Slightly volatile
Cash Per Share1.141.27.7887
Slightly volatile
Days Payables Outstanding6246574.4 K
Very volatile
Intangibles To Total Assets0.340.250.3197
Slightly volatile
Current Ratio11.9814.0516.6046
Slightly volatile
Tangible Book Value Per Share1.071.1210.9003
Slightly volatile
Receivables Turnover0.80.90.9805
Slightly volatile
Graham Number2.442.5725.5121
Slightly volatile
Shareholders Equity Per Share1.391.4611.3403
Slightly volatile
Debt To Equity0.00380.0040.3601
Slightly volatile
Capex Per Share5.0E-45.0E-40.014
Slightly volatile
Average Receivables2.4 M2.7 M2.9 M
Slightly volatile
Revenue Per Share0.02230.02340.6837
Slightly volatile
Interest Debt Per Share0.00480.00510.4698
Slightly volatile
Debt To Assets0.00360.00370.2707
Slightly volatile
Operating Cycle292329358
Slightly volatile
Price Book Value Ratio1.631.062.5778
Very volatile
Days Of Payables Outstanding6246574.4 K
Very volatile
Ebt Per Ebit0.951.00.9804
Slightly volatile
Company Equity Multiplier1.681.221.1709
Pretty Stable
Long Term Debt To Capitalization0.390.320.2962
Very volatile
Total Debt To Capitalization0.00380.0040.2032
Slightly volatile
Debt Equity Ratio0.00380.0040.3601
Slightly volatile
Quick Ratio11.9814.0516.6046
Slightly volatile
Net Income Per E B T0.670.90.9026
Pretty Stable
Cash Ratio9.1514.014.3037
Slightly volatile
Days Of Sales Outstanding292329358
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0185
Slightly volatile
Price To Book Ratio1.631.062.5778
Very volatile
Fixed Asset Turnover1.761.858.6468
Slightly volatile
Debt Ratio0.00360.00370.2707
Slightly volatile
Price Sales Ratio10784.642.2666
Slightly volatile
Asset Turnover0.01650.01740.0455
Slightly volatile
Gross Profit Margin0.230.40.4072
Very volatile
Price Fair Value1.631.062.5778
Very volatile

MediciNova Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap99.2 M90.5 M135.7 M
Pretty Stable
Enterprise Value82.8 M74 M109.7 M
Pretty Stable

MediciNova Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MediciNova Financial Statements

MediciNova investors use historical fundamental indicators, such as MediciNova's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.2 M2.1 M
Cost Of Revenue18.3 K17.4 K
Stock Based Compensation To Revenue 0.82  0.78 
Sales General And Administrative To Revenue 5.73  5.45 
Research And Ddevelopement To Revenue 6.51  6.18 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(8.91)(9.36)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY